VJOncology is committed to improving our service to you

ASCO 2019 | Immunotherapy and targeted therapy for advanced aRCC

VJOncology is committed to improving our service to you

James Brugarolas

James Brugarolas, MD, PhD, from the University of Texas Southwestern Medical Center, Dallas, TX, talks about immunotherapy for advanced renal cell carcinoma (aRCC). This interview was recorded at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter